WTAP anticorps (AA 1-151)

N° du produit ABIN7164194

Détail du produit anti-WTAP anticorps

Antigène: WTAP (Wilms Tumor 1 Associated Protein (WTAP))

Épitope: AA 1-151

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp WTAP est non-conjugé

Application: Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)

Réactivité croisée: Humain, Souris, Rat

Purification: >95%, Protein G purified

Immunogène: Recombinant Human Pre-mRNA-splicing regulator WTAP protein (1-151AA)

Isotype: IgG

Information d'application

Indications d'application: Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:200, IF:1:50-1:200,

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur WTAP

Antigène: WTAP (Wilms Tumor 1 Associated Protein (WTAP))

Autre désignation: WTAP (WTAP Produits)

Synonymes: anticorps MGC75954, anticorps WTAP, anticorps RGD1563824, anticorps wu:fi29a09, anticorps zgc:66202, anticorps 2810408K05Rik, anticorps 9430038B09Rik, anticorps WT1 associated protein, anticorps Wilms tumor 1 associated protein, anticorps wilms tumor 1 associated protein, anticorps WT1 associated protein L homeolog, anticorps Wilms tumour 1-associating protein, anticorps wtap, anticorps WTAP, anticorps CpipJ_CPIJ006489, anticorps Wtap, anticorps wtap.L

Sujet:

Background: Regulatory subunit of the WMM N6-methyltransferase complex, a multiprotein complex that mediates N6-methyladenosine (m6A) methylation of some adenosine residues of some mRNAs and plays a role in the efficiency of mRNA splicing, processing and mRNA stability. Required for accumulation of METTL3 and METTL14 to nuclear speckle (PubMed:24316715, PubMed:24407421, PubMed:24981863). Acts as a mRNA splicing regulator (PubMed:12444081). Regulates G2/M cell-cycle transition by binding to the 3\\\' UTR of CCNA2, which enhances its stability (PubMed:17088532). Impairs WT1 DNA-binding ability and inhibits expression of WT1 target genes (PubMed:17095724).

Aliases: DKFZp686F20131 antibody, Female-lethal(2)D homolog antibody, FL2D_HUMAN antibody, hFL(2)D antibody, KIAA0105 antibody, MGC3925 antibody, Mum2 antibody, OTTHUMP00000017522 antibody, OTTHUMP00000017523 antibody, PNAS 132 antibody, PNAS-132 antibody, PNAS132 antibody, Pre mRNA splicing regulator WTAP antibody, Pre-mRNA-splicing regulator WTAP antibody, Putative pre mRNA splicing regulator female lethal 2D homolog antibody, Putative pre mRNA splicing regulator female lethal(2D) antibody, Putative pre-mRNA splicing regulator female lethal(2D) homolog antibody, putative pre-mRNA splicing regulator female-lethal(2D) antibody, Wilms tumor 1 associated protein antibody, Wilms tumor 1 associating protein antibody, Wilms tumor 1-associating protein antibody, Wilms' tumor 1 associating protein antibody, Wilms' tumour 1-associating protein antibody, WT1 associated protein antibody, WT1-associated protein antibody, WT1-associating protein antibody, wtap antibody

UniProt: Q15007